Clinical Trials Browser

Iodine-124 × 30 days × Clear all

NCT03841617 2026-06-05

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

Phase 2 Recruiting

Neoplasm Metastasis, Thyroid Neoplasms

NCT01704586 2026-05-12

CLERAD-PROBE

Phase NA Active not recruiting

EndocrineHead & Neck

Differentiated Thyroid Carcinoma